Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 15, 2017
Total Value: $689M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TBPH | THERAVANCE BIOPHARMA INC | 1,425,000 | $52.47M | 7.6% | $23.62 | +35.2% | COM | G8807B106 |
| — | NEVRO CORP | 350,000 | $32.8M | 4.8% | $57.41 | — | COM | 64157F103 |
| — | PROTEOSTASIS THERAPEUTICS IN | 3,804,027 | $29.75M | 4.3% | $12.20 | — | COM | 74373B109 |
| GLPG | GALAPAGOS NV | 300,000 | $26.07M | 3.8% | $54.92 | — | SPON ADR | 36315X101 |
| ANAB | ANAPTYSBIO INC | 895,626 | $24.85M | 3.6% | $23.32 | 0.0% | COM | 032724106 |
| ARDX | ARDELYX INC | 1,922,738 | $24.32M | 3.5% | $15.57 | -15.5% | COM | 039697107 |
| — | BLUEPRINT MEDICINES CORP | 600,000 | $23.99M | 3.5% | $27.50 | — | COM | 09627Y109 |
| ACRS | ACLARIS THERAPEUTICS INC | 800,000 | $23.86M | 3.5% | $19.94 | +44.6% | COM | 00461U105 |
| — | PORTOLA PHARMACEUTICALS INC | 600,000 | $23.51M | 3.4% | $26.08 | — | COM | 737010108 |
| — | ALDER BIOPHARMACEUTICALS INC | 1,098,205 | $22.84M | 3.3% | $32.02 | — | COM | 014339105 |
| — | QUOTIENT LTD | 2,899,000 | $20.26M | 2.9% | $11.01 | — | SHS | G73268107 |
| — | MINERVA NEUROSCIENCES INC | 2,307,903 | $18.69M | 2.7% | $7.26 | — | COM | 603380106 |
| HRTX | HERON THERAPEUTICS INC | 1,200,000 | $18M | 2.6% | $15.72 | -12.0% | COM | 427746102 |
| EGRX | EAGLE PHARMACEUTICALS INC | 200,000 | $16.59M | 2.4% | $40.56 | +83.3% | COM | 269796108 |
| — | CLEARSIDE BIOMEDICAL INC | 1,940,880 | $15.41M | 2.2% | $7.30 | — | COM | 185063104 |
| — | MYOKARDIA INC | 1,130,000 | $14.86M | 2.2% | $15.55 | — | COM | 62857M105 |
| — | JUNO THERAPEUTICS INC | 650,000 | $14.42M | 2.1% | $22.19 | — | COM | 48205A109 |
| — | CORBUS PHARMACEUTICALS HLDGS | 1,686,100 | $13.91M | 2.0% | $4.08 | — | COM | 21833P103 |
| WVE | WAVE LIFE SCIENCES LTD | 482,079 | $13.26M | 1.9% | $17.46 | +60.0% | SHS | Y95308105 |
| CHRS | COHERUS BIOSCIENCES INC | 620,300 | $13.12M | 1.9% | $21.55 | +14.2% | COM | 19249H103 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 300,000 | $12.99M | 1.9% | $15.30 | +180.1% | COM | 64125C109 |
| — | FORWARD PHARMA A/S | 589,175 | $12.7M | 1.8% | $22.82 | — | SPONSORED ADR | 34986J105 |
| OMER | OMEROS CORP | 750,000 | $11.34M | 1.6% | $15.02 | -27.2% | COM | 682143102 |
| — | ZYNERBA PHARMACEUTICALS INC | 500,000 | $10.05M | 1.5% | $13.30 | — | COM | 98986X109 |
| — | CHINA BIOLOGIC PRODUCTS INC | 100,000 | $10.01M | 1.5% | $67.14 | — | COM | 16938C106 |
| — | GEMPHIRE THERAPEUTICS INC | 952,798 | $10M | 1.5% | $10.90 | — | COM | 36870A108 |
| — | JOUNCE THERAPEUTICS INC | 434,976 | $9.565M | 1.4% | $21.99 | — | COM | 481116101 |
| — | INC RESH HLDGS INC | 200,000 | $9.17M | 1.3% | $38.13 | — | CL A | 45329R109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 683,600 | $8.757M | 1.3% | $13.67 | +17.9% | COM | 74366E102 |
| FLGT | FULGENT GENETICS INC | 750,000 | $8.19M | 1.2% | $9.22 | +28.3% | COM | 359664109 |
| — | ARRAY BIOPHARMA INC | 900,000 | $8.046M | 1.2% | $6.75 | — | COM | 04269X105 |
| — | AUDENTES THERAPEUTICS INC | 424,660 | $7.236M | 1.1% | $17.81 | — | COM | 05070R104 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,690,800 | $6.679M | 1.0% | $9.12 | -45.0% | COM NEW | 83587F202 |
| — | RIGEL PHARMACEUTICALS INC | 2,000,000 | $6.62M | 1.0% | $2.90 | — | COM NEW | 766559603 |
| — | CONTRAFECT CORP | 3,550,000 | $6.39M | 0.9% | $2.80 | — | COM | 212326102 |
| — | INVUITY INC | 756,470 | $6.014M | 0.9% | $13.53 | — | COM NEW | 46187J205 |
| DXCM | DEXCOM INC | 70,000 | $5.931M | 0.9% | $7.91 | +146.6% | COM | 252131107 |
| — | DERMIRA INC | 170,000 | $5.799M | 0.8% | $18.24 | — | COM | 24983L104 |
| — | SYNERGY PHARMACEUTICALS INC | 1,200,000 | $5.592M | 0.8% | $6.09 | — | COM NEW | 871639308 |
| — | CURIS INC | 2,000,000 | $5.56M | 0.8% | $2.44 | — | COM | 231269101 |
| — | RECRO PHARMA INC | 590,000 | $5.157M | 0.7% | $7.16 | — | COM | 75629F109 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 75,000 | $5.084M | 0.7% | $51.16 | +49.0% | COM | 90400D108 |
| — | AGENUS INC | 1,200,000 | $4.524M | 0.7% | $4.53 | — | COM NEW | 00847G705 |
| — | INTEC PHARMA LTD JERUSALEM | 809,804 | $4.14M | 0.6% | $5.59 | — | SHS | M53644106 |
| — | AGILE THERAPEUTICS INC | 1,250,000 | $4.006M | 0.6% | $4.95 | — | COM | 00847L100 |
| CTMX | CYTOMX THERAPEUTICS INC | 230,000 | $3.972M | 0.6% | $15.82 | -16.8% | COM | 23284F105 |
| — | PFENEX INC | 574,966 | $3.341M | 0.5% | $16.67 | — | COM | 717071104 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 240,403 | $3.298M | 0.5% | $12.61 | -17.6% | COM | 87164F105 |
| SGMO | SANGAMO THERAPEUTICS INC | 600,000 | $3.12M | 0.5% | $6.37 | -37.1% | COM | 800677106 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 300,000 | $3.018M | 0.4% | $17.28 | -14.0% | COM | 19459J104 |
| — | ADVANCED ACCELERATOR APPLIC | 75,000 | $2.99M | 0.4% | $26.76 | — | SPONSORED ADS | 00790T100 |
| — | LIPOCINE INC | 741,496 | $2.892M | 0.4% | $6.47 | — | COM | 53630X104 |
| ASND | ASCENDIS PHARMA A S | 100,000 | $2.8M | 0.4% | $19.11 | — | SPONSORED ADR | 04351P101 |
| — | ONCOBIOLOGICS INC | 1,002,516 | $2.687M | 0.4% | $3.28 | — | COM | 68235M105 |
| — | EPIZYME INC | 140,000 | $2.401M | 0.3% | $18.78 | — | COM | 29428V104 |
| RGNX | REGENXBIO INC | 120,000 | $2.316M | 0.3% | $25.52 | -24.4% | COM | 75901B107 |
| — | IMMUNE DESIGN CORP | 337,000 | $2.292M | 0.3% | $12.79 | — | COM | 45252L103 |
| — | AVEXIS INC | 30,000 | $2.281M | 0.3% | $41.21 | — | COM | 05366U100 |
| — | SUNESIS PHARMACEUTICALS INC | 520,183 | $2.133M | 0.3% | $3.62 | — | COM PAR | 867328700 |
| — | TIGENIX | 129,032 | $2.013M | 0.3% | $14.58 | — | SPONSORED ADS | 88675R109 |
| — | ABEONA THERAPEUTICS INC | 400,000 | $2M | 0.3% | $4.85 | — | COM | 00289Y107 |
| — | ACCELERON PHARMA INC | 75,000 | $1.985M | 0.3% | $32.04 | — | COM | 00434H108 |
| XNCR | XENCOR INC | 75,000 | $1.794M | 0.3% | $24.05 | +0.2% | COM | 98401F105 |
| CRVS | CORVUS PHARMACEUTICALS INC | 81,000 | $1.682M | 0.2% | $13.51 | +16.0% | COM | 221015100 |
| — | GLYCOMIMETICS INC | 287,031 | $1.559M | 0.2% | $16.22 | — | COM | 38000Q102 |
| — | HTG MOLECULAR DIAGNOSTICS IN | 203,464 | $1.408M | 0.2% | $11.05 | — | COM | 40434H104 |
| — | MYOVANT SCIENCES LTD | 100,000 | $1.174M | 0.2% | $12.44 | — | COM | G637AM102 |
| — | APTOSE BIOSCIENCES INC | 990,579 | $1.01M | 0.1% | $5.91 | — | COM NEW | 03835T200 |
| — | THRESHOLD PHARMACEUTICAL INC | 900,000 | $513K | 0.1% | $0.48 | — | COM NEW | 885807206 |
| — | AVEO PHARMACEUTICALS INC | 700,000 | $413K | 0.1% | $1.74 | — | COM | 053588109 |
| — | NEOS THERAPEUTICS INC | 50,613 | $364K | 0.1% | $20.88 | — | COM | 64052L106 |
| — | ONCOBIOLOGICS INC | 416,666 | $333K | 0.0% | $0.46 | — | *W EXP 02/18/201 | 68235M113 |
| — | ONCOBIOLOGICS INC | 416,666 | $208K | 0.0% | $0.45 | — | *W EXP 05/18/201 | 68235M121 |
| — | CELLECTAR BIOSCIENCES INC | 53,649 | $122K | 0.0% | $3.40 | — | COM | 15117F302 |
| — | CELLECTAR BIOSCIENCES INC | 52,999 | $20,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |